| MolName | 1-[(2R,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-2-enylpyrimidine-2,4-dione |
| MolecularFormula | C12H16N2O5 |
| Smiles | C=CCC(C(N1)=O)=CN([C@@H](C2)O[C@@H](CO)[C@@H]2O)C1=O |
| InChI | InChI=1S/C12H16N2O5/c1-2-3-7-5-14(12(18)13-11(7)17)10-4-8(16)9(6-15)19-10/h2,5,8-10,15-16H,1,3-4,6H2,(H,13,17,18)/t8-,9+,10+/m0/s1 |
| InChIK | XUAFMQXKGPTTJN-IVZWLZJFSA-N |
| TotalMolweight | 268.268 |
| Molweight | 268.268 |
| MonoisotopicMass | 268.105923 |
| CLogP | -0.5276 |
| CLogS | -1.593 |
| H Acceptors | 7 |
| H Donors | 3 |
| TotalSurfaceArea | 194.49 |
| Relative PSA | 0.3974 |
| PolarSurfaceArea | 99.1 |
| Druglikeness | 1.1816 |
| Mutagenic | high |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.57895 |
| Fragments | 1 |
| Non HAtoms | 19 |
| NonCHAtoms | 7 |
| Electronegative Atoms | 7 |
| StereoCenters | 3 |
| Rotatable Bond | 4 |
| Rings Closures | 2 |
| Small Rings | 2 |
| Sp3Atoms | 9 |
| Amides | 2 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - 1-[(2R,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-2-enylpyrimidine-2,4-dione | 2 - 1-[(2R,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-2-enylpyrimidine-2,4-dione